PT - JOURNAL ARTICLE AU - Ou, Xumin AU - Yang, Zhishuang AU - Zhu, Dekang AU - Mao, Sai AU - Wang, Mingshu AU - Jia, Renyong AU - Chen, Shun AU - Liu, Mafeng AU - Yang, Qiao AU - Wu, Ying AU - Zhao, Xinxin AU - Zhang, Shaqiu AU - Huang, Juan AU - Gao, Qun AU - Liu, Yunya AU - Zhang, Ling AU - Peopplenbosch, Maikel AU - Pan, Qiuwei AU - Cheng, Anchun TI - Microbial GWAS studies revealing combinations of Omicron RBD mutations existed and may contribute to antibody evasion and ACE2 binding AID - 10.1101/2022.01.19.22269510 DP - 2022 Jan 01 TA - medRxiv PG - 2022.01.19.22269510 4099 - http://medrxiv.org/content/early/2022/01/21/2022.01.19.22269510.short 4100 - http://medrxiv.org/content/early/2022/01/21/2022.01.19.22269510.full AB - Since Omicron variant of SARS-CoV-2 was first detected in South Africa (SA), it has now dominated in United Kingdom (UK) of Europe and United State (USA) of North America. A prominent feature of this variant is the gathering of spike protein mutations, in particularly at the receptor binding domain (RBD). These RBD mutations essentially contribute to antibody resistance of current immune approaches. During global spillover, combinations of RBD mutations may exist and synergistically contribute to antibody resistance in fact. Using three geographic-stratified genome wide association studies (GWAS), we observed that RBD combinations exhibited a geographic pattern and genetical associated, such as five common mutations in both UK and USA Omicron, six or two specific mutations in UK or USA Omicron. Although the UK specific RBD mutations can be further classified into two separated sub-groups of combination based on linkage disequilibrium analysis. Functional analysis indicated that the common RBD combinations (fold change, -11.59) alongside UK or USA specific mutations significantly reduced neutralization (fold change, -38.72, -18.11). As RBD overlaps with angiotensin converting enzyme 2(ACE2) binding motif, protein-protein contact analysis indicated that the common RBD mutations enhanced ACE2 binding accessibility and were further strengthened by UK or USA-specific RBD mutations. Spatiotemporal evolution analysis indicated that UK-specific RBD mutations largely contribute to global spillover. Collectively, we have provided genetic evidence of RBD combinations and estimated their effects on antibody evasion and ACE2 binding accessibility.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by National Natural Science Foundation of China (32102706 to X. Ou), Sichuan Veterinary Medicine and Drug Innovation Group of China Agricultural Research System (SCCXTD-2021-18), Science and Technology Program of Sichuan Province (2020YJ0396 to X. Ou), China Agriculture Research System of MOF and MARA.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data and processed CSV files are available at supplementary dataset or with contacts to corresponding author for details.